Amplify Treatments, Testing And Advancements ETF BIO Holdings History
Amplify Treatments, Testing and Advancements ETF's Bio-Rad Laboratories Inc Holding Summary
As of 2024-06-30, Amplify Treatments, Testing and Advancements ETF held 1,354.00 shares of Bio-Rad Laboratories Inc(BIO), totaling $369,790.00. This investment constitutes 4.05% of their stock portfolio, and Amplify Treatments, Testing and Advancements ETF now holds 0% of the outstanding Bio-Rad Laboratories Inc(BIO) stock.
The initial trade took place in 2024Q1. And since then Amplify Treatments, Testing and Advancements ETF has made 1 purchases of BIO, at an average price of $328.53, for a total of 1,354.00 shares. Based on historical transaction data and BIO's current price of $244.72, Amplify Treatments, Testing and Advancements ETF's estimated gain on his BIO holdings is $-113,480.59, reflecting a -25.51% gain to date.
Amplify Treatments, Testing and Advancements ETF BIO ($244.72) Holding Chart
Amplify Treatments, Testing and Advancements ETF BIO ($244.72) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
